drugset / Trial / NCT01634165
A Study of LY2963016 in Healthy Participants
RandomizedCrossoverDouble-blindBasic science
Summary
This study involves 2 single injections of LY2963016 and 2 single injections of Lantus. There will be at least 6 days between each injection. The study will compare LY2963016 to Lantus at two different doses. This study is approximately 10 weeks long, not including screening. Screening is required within 4 weeks of the start of the study.
Timeline
- Start
- 2012-07
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2963016 | Protein / enzyme biologic | 0.3 iu/kg | Subcutaneous |
| Subject | LY2963016 | Protein / enzyme biologic | 0.6 iu/kg | Subcutaneous |
| Subject | insulin glargine | Protein / enzyme biologic | 0.3 iu/kg | Subcutaneous |
| Subject | insulin glargine | Protein / enzyme biologic | 0.6 iu/kg | Subcutaneous |
Indications
No indication recorded.